603127.SH
JOINN Laboratories (China) Co., Ltd.
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 46.39
−5.85%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 44.64
From 52W high−13.93%
Volume47.83M
Market capCNY 34.76B
P/E (TTM)116.7x
P/S (TTM)20.3x
Div yield0.26%
Key dataSep 18, 2026
Open
CNY 44.64
From 52W high
−13.93%
Volume
47.83M
Market cap
CNY 34.76B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
71.0x
P/E (TTM)
116.7x
RSI (14)
52.1
MomentumView details →
1D Return
−5.85%
YTD Return
+30.71%
Similar companies
Latest newsMore news →
On September 8, 2026, Joinn Laboratories held its 2026 interim results briefing, reporting H1 2026 revenue of 704 million yuan (up 5.27% year-on-year) and net profit attributable to shareholders of 748 million yuan (up 1126.8% year-on-year), driven largely by a 735 million yuan fair value gain on biological assets, while its core laboratory services business remained loss-making.12d agoJoinn Laboratories released its 2026 interim report on August 28, reporting net profit attributable to shareholders of 748 million yuan, up 1126.8% year-on-year, and revenue of 704 million yuan, up 5.27% year-on-year.23d agoJoinn Laboratories (06127) issued a profit alert, expecting a significant increase in net profit for the first half of 2026 due to a rise in biological asset market prices.67d ago